Paper36928854
The Difficult Path to the Discovery of Novel Treatments in Psychiatric Disorders.
Gribkoff VK and 1 other. Adv Neurobiol, 2023. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. The Difficult Path to the Discovery of Novel Treatments in Psychiatric Disorders. Papers, record 36928854. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36928854
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mental Disorders | Major topic |
| Animals | |
| Humans | |
| Biomarkers |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 NS102239 | NINDS NIH HHS | United States | R01NS102239 | PubMed and NIH |
Source NIH RePORTER
References169
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32346293 | Association Analysis Between SNPs in the Promoter Region of RGS4 and Schizophrenia in the Northern Chinese Han Population. | Neuropsychiatr Dis Treat | 2020 | https://conductscience.org/library/papers/32346293 | PubMed |
| 2 | 28771182 | New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28771182 | PubMed |
| 3 | 31664453 | Schizophrenia-An Overview. | JAMA Psychiatry | 2020 | https://conductscience.org/library/papers/31664453 | PubMed |
| 4 | 33424663 | First-Episode Psychotic Patients Showed Longitudinal Brain Changes Using fMRI With an Emotional Auditory Paradigm. | Front Psychiatry | 2020 | https://conductscience.org/library/papers/33424663 | PubMed |
| 5 | 25194482 | Potassium channel genes and benign familial neonatal epilepsy. | Prog Brain Res | 2014 | https://conductscience.org/library/papers/25194482 | PubMed |
| 6 | 29413518 | Unique Effects of Clozapine: A Pharmacological Perspective. | Adv Pharmacol | 2018 | https://conductscience.org/library/papers/29413518 | PubMed |
| 7 | 28468935 | Neurodegenerative disease: models, mechanisms, and a new hope. | Dis Model Mech | 2017 | https://conductscience.org/library/papers/28468935 | PubMed |
| 8 | 28544755 | A gene-based review of RGS4 as a putative risk gene for psychiatric illness. | Am J Med Genet B Neuropsychiatr Genet | 2018 | https://conductscience.org/library/papers/28544755 | PubMed |
| 9 | 32054370 | Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects. | Expert Opin Drug Metab Toxicol | 2020 | https://conductscience.org/library/papers/32054370 | PubMed |
| 10 | 11593073 | A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia. | J Clin Psychopharmacol | 2001 | https://conductscience.org/library/papers/11593073 | PubMed |
| 11 | 32294346 | A Non-D2-Receptor-Binding Drug for the Treatment of Schizophrenia. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32294346 | PubMed |
| 12 | 29474680 | Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1. | Schizophr Bull | 2019 | https://conductscience.org/library/papers/29474680 | PubMed |
| 13 | 20628954 | Toward standardized usage of the word serendipity in the historiography of psychopharmacology. | J Hist Neurosci | 2010 | https://conductscience.org/library/papers/20628954 | PubMed |
| 14 | 19300578 | Fifty years chlorpromazine: a historical perspective. | Neuropsychiatr Dis Treat | 2007 | https://conductscience.org/library/papers/19300578 | PubMed |
| 15 | 30250265 | Animal models of neurodegenerative diseases. | Nat Neurosci | 2018 | https://conductscience.org/library/papers/30250265 | PubMed |
| 16 | 31963851 | In Vitro and In Vivo Models for the Investigation of Potential Drugs Against Schizophrenia. | Biomolecules | 2020 | https://conductscience.org/library/papers/31963851 | PubMed |
| 17 | 28397113 | Managing Negative Symptoms of Schizophrenia: How Far Have We Come? | CNS Drugs | 2017 | https://conductscience.org/library/papers/28397113 | PubMed |
| 18 | 33397140 | Neuroimaging Biomarkers in Schizophrenia. | Am J Psychiatry | 2021 | https://conductscience.org/library/papers/33397140 | PubMed |
| 19 | 23686171 | NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. | Nat Rev Neurosci | 2013 | https://conductscience.org/library/papers/23686171 | PubMed |
| 20 | 32682869 | Treatment of Multiple Sclerosis: A Review. | Am J Med | 2020 | https://conductscience.org/library/papers/32682869 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42016024 | Trace Amine-associated Receptor 1: Role in the Implementation of Neuroprotective Signaling Pathways. | Int J Mol Cell Med | 2025 | https://conductscience.org/library/papers/42016024 | PubMed |
| 41226359 | Special Issue "Molecular Mechanisms of Neurological and Psychiatric Disease: A Decade of Progress". | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226359 | PubMed |
| 39061448 | The Advantages of Combining Therapies in Treating Psychiatric Patients. | Brain Sci | 2024 | https://conductscience.org/library/papers/39061448 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACHE | 43 | PubTator's text mining | https://conductscience.org/library/genes/43 | NCBI Gene |
| DRD1 | 1812 | PubTator's text mining | https://conductscience.org/library/genes/1812 | NCBI Gene |
| DRD2 | 1813 | PubTator's text mining | https://conductscience.org/library/genes/1813 | NCBI Gene |
| FMR1 | 2332 | PubTator's text mining | https://conductscience.org/library/genes/2332 | NCBI Gene |
| HTR1A | 3350 | PubTator's text mining | https://conductscience.org/library/genes/3350 | NCBI Gene |
| KCNMA1 | 3778 | PubTator's text mining | https://conductscience.org/library/genes/3778 | NCBI Gene |
| KCNT1 | 57582 | PubTator's text mining | https://conductscience.org/library/genes/57582 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| RGS4 | 5999 | PubTator's text mining | https://conductscience.org/library/genes/5999 | NCBI Gene |
| TAAR1 | 134864 | PubTator's text mining | https://conductscience.org/library/genes/134864 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36928854
GET https://conductscience.org/api/papers/v1/36928854/references?page=2